Nakajima Madoka, Arai Hajime, Miyajima Masakazu
Department of Neurosurgery, Juntendo University School of Medicine.
Rinsho Shinkeigaku. 2010 Nov;50(11):973-6. doi: 10.5692/clinicalneurol.50.973.
Cerebrospinal fluid (CSF) shunting can improve symptoms of elderly patients idiopathic normal pressure hydrocephalus (iNPH). However, adjunctive means for confirming the diagnosis remain unavailable. We have previously reported specific increase of leucine-rich alpha-2-glycoprotein (LRG) in iNPH CSF, and present study investigates its potential clinical applications.
We performed CSF tap test (TT) on 90 patients and shunting in 52 patients (mean age 73.5 years), evaluating symptom improvement and higher cerebral functions-MMSE and Frontal Assessment Battery (FAB) before and twelve months after shunting. LRG and tau protein concentrations in TT CSF were simultaneously measured using ELIZA. Then we compared the predictive value of these concentrations with TT results regarding successful shunting outcomes.
Positive combinations of TT and LRG concentrations of 67 ng/mL or higher, gave 81.6% sensitivity and 78.6% specificity. Therefore we used LRG (67 ng/mL) and tau (200 pg/mL) cutoff values, LRG ≥ 67 ng/ml and tau < 200 pg/ml, 31 of 34 patients (91.2%) had a positive TT and all operated 22 patients were shunt responders. Dementia MMSE and FAB scores in them increased from a baseline of 22.05 to 25.65 and 11.38 to 13.08 respectively.
A combination of positive TT and biomarkers quantification such as LRG and tau protein, can reliably predict shunting outcome in iNPH patients.
脑脊液分流术可改善老年特发性正常压力脑积水(iNPH)患者的症状。然而,目前仍缺乏辅助诊断方法。我们之前报道过iNPH患者脑脊液中富含亮氨酸的α-2-糖蛋白(LRG)特异性升高,本研究探讨其潜在的临床应用价值。
我们对90例患者进行了脑脊液穿刺试验(TT),并对52例患者(平均年龄73.5岁)进行了分流术,评估了分流术前及术后12个月症状的改善情况以及高级脑功能——简易精神状态检查表(MMSE)和额叶评估量表(FAB)。使用酶联免疫吸附测定法(ELISA)同时检测TT脑脊液中LRG和tau蛋白的浓度。然后我们将这些浓度的预测价值与TT结果进行比较,以判断分流术的成功效果。
TT阳性且LRG浓度≥67 ng/mL的组合,敏感性为81.6%,特异性为78.6%。因此,我们采用LRG(67 ng/mL)和tau(200 pg/mL)的临界值,即LRG≥67 ng/ml且tau<200 pg/ml,34例患者中有31例(91.2%)TT结果为阳性,所有接受手术的22例患者均为分流术有效者。他们的痴呆MMSE和FAB评分分别从基线的22.05提高到25.65,从11.38提高到13.08。
TT阳性与LRG和tau蛋白等生物标志物定量相结合,能够可靠地预测iNPH患者的分流术效果。